MX2019007902A - Composiciones para el tratamiento de seres humanos. - Google Patents

Composiciones para el tratamiento de seres humanos.

Info

Publication number
MX2019007902A
MX2019007902A MX2019007902A MX2019007902A MX2019007902A MX 2019007902 A MX2019007902 A MX 2019007902A MX 2019007902 A MX2019007902 A MX 2019007902A MX 2019007902 A MX2019007902 A MX 2019007902A MX 2019007902 A MX2019007902 A MX 2019007902A
Authority
MX
Mexico
Prior art keywords
treatment
microbial lysozyme
inflammatory bowel
bowel disease
bowel syndrome
Prior art date
Application number
MX2019007902A
Other languages
English (en)
Inventor
Thorup COHN Marianne
Ny KRISTENSEN Nanna
Kjaerulff Soeren
Original Assignee
Novozymes As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes As filed Critical Novozymes As
Publication of MX2019007902A publication Critical patent/MX2019007902A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/195—Proteins from microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01017—Lysozyme (3.2.1.17)

Abstract

La presente invención se refiere a la lisozima microbiana, composiciones que la comprenden y usos de la misma.
MX2019007902A 2017-01-04 2018-01-04 Composiciones para el tratamiento de seres humanos. MX2019007902A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP17150258 2017-01-04
EP17155110 2017-02-08
EP17209209 2017-12-21
PCT/EP2018/050189 WO2018127532A1 (en) 2017-01-04 2018-01-04 Microbial lysozyme for use in the treatment of irritable bowel syndrome or inflammatory bowel disease

Publications (1)

Publication Number Publication Date
MX2019007902A true MX2019007902A (es) 2019-09-09

Family

ID=61022310

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019007902A MX2019007902A (es) 2017-01-04 2018-01-04 Composiciones para el tratamiento de seres humanos.

Country Status (13)

Country Link
US (2) US11179447B2 (es)
EP (2) EP3565582B1 (es)
JP (1) JP7319920B2 (es)
KR (1) KR20190103234A (es)
CN (1) CN110267676A (es)
AU (1) AU2018205999A1 (es)
BR (1) BR112019013574A2 (es)
CA (1) CA3048773A1 (es)
ES (1) ES2915100T3 (es)
IL (1) IL267767A (es)
MX (1) MX2019007902A (es)
MY (1) MY191930A (es)
WO (1) WO2018127532A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112019012802A2 (pt) 2016-12-21 2019-12-03 Novozymes As polipeptídeo gh25 isolado, métodos para hidrolisar peptidoglicano em paredes celulares bacterianas, para aumentar a digestibilidade de peptidoglicanos em ração animal, para produzir o polipeptídeo, para aperfeiçoar a saúde intestinal em um animal e para promover a eliminação de células de lactobacillus johnsonii mortas, aditivo de ração animal, ração animal, composição, polinucleotídeo, célula hospedeira recombinante, uso do polipeptídeo, e, aditivo zootécnico para uso em ração
WO2018113743A1 (en) 2016-12-21 2018-06-28 Novozymes A/S Polypeptides having lysozyme activity, polynucleotides encoding same and uses and compositions thereof
CN112439055A (zh) * 2019-08-29 2021-03-05 湘北威尔曼制药股份有限公司 用于预防或治疗尿酸性疾病的组合物
CN112704730A (zh) * 2019-10-25 2021-04-27 湘北威尔曼制药股份有限公司 预防或治疗肠易激综合征的药物组合
US20240034960A1 (en) 2020-08-27 2024-02-01 Danisco Us Inc Enzymes and enzyme compositions for cleaning

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK122686D0 (da) 1986-03-17 1986-03-17 Novo Industri As Fremstilling af proteiner
AU753232B2 (en) 1998-10-15 2002-10-10 Dsm N.V. Antimicrobial enzymes in animal feed
AU2002223504A1 (en) 2000-11-17 2002-05-27 Novozymes A/S Heterologous expression of taxanes
CA2404356A1 (en) 2002-09-18 2004-03-18 Canadian Inovatech Inc. Gram-positive antibacterial composition and method for use
GB2379166A (en) 2002-10-22 2003-03-05 Dsm Nv Animal feed
WO2005042735A1 (en) 2003-10-30 2005-05-12 Novozymes A/S Carbohydrate-binding modules of a new family
US20100003235A1 (en) 2005-09-28 2010-01-07 Hagie Frank E Oral formulations for enteric disorders and/or rehydration
JP2009263307A (ja) 2008-04-28 2009-11-12 Taiyo Kagaku Co Ltd 炎症性腸疾患の予防・治療剤
WO2012027282A2 (en) 2010-08-23 2012-03-01 Codexis, Inc. Recombinant lignocellulose degradation enzymes for the production of soluble sugars from cellulosic biomass
WO2012027374A2 (en) 2010-08-23 2012-03-01 Dyadic International (Usa) Inc. Novel fungal carbohydrate hydrolases
EP2782592B1 (en) 2011-11-25 2017-03-15 Novozymes A/S Polypeptides having lysozyme activity and polynucleotides encoding same
AU2013348178A1 (en) 2012-11-20 2015-05-14 Shell Internationale Research Maatschappij B.V. Recombinant fungal polypeptides
CN107809912B (zh) * 2015-07-02 2022-07-15 诺维信公司 动物饲料组合物及其用途
WO2017001703A1 (en) * 2015-07-02 2017-01-05 Novozymes A/S Methods of improving animal performance

Also Published As

Publication number Publication date
JP2020513771A (ja) 2020-05-21
US20220118061A1 (en) 2022-04-21
MY191930A (en) 2022-07-19
EP4052722A1 (en) 2022-09-07
US11179447B2 (en) 2021-11-23
EP3565582B1 (en) 2022-03-09
BR112019013574A2 (pt) 2020-06-23
IL267767A (en) 2019-09-26
EP3565582A1 (en) 2019-11-13
KR20190103234A (ko) 2019-09-04
CA3048773A1 (en) 2018-07-12
CN110267676A (zh) 2019-09-20
ES2915100T3 (es) 2022-06-20
JP7319920B2 (ja) 2023-08-02
US20190351032A1 (en) 2019-11-21
AU2018205999A1 (en) 2019-06-27
WO2018127532A1 (en) 2018-07-12

Similar Documents

Publication Publication Date Title
ZA201905488B (en) Tigit- and light-based chimeric proteins
CY1122184T1 (el) Συνθεσεις περιλαμβανουσες βακτηριακα στελεχη
EA201891199A1 (ru) Композиции, содержащие бактериальные штаммы
CY1124013T1 (el) Συνθεσεις που περιλαμβανουν βακτηριακα στελεχη
EA201890048A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890047A1 (ru) Композиции, содержащие бактериальные штаммы
EA201891202A1 (ru) Композиции, содержащие бактериальные штаммы
MX2021000077A (es) Composiciones que comprenden cepas bacterianas.
EA201891201A1 (ru) Композиции, содержащие бактериальные штаммы
MX2019007902A (es) Composiciones para el tratamiento de seres humanos.
IL263556B (en) Preparations containing bacterial strains of the genus Blautia hydrogenotrophia for use in the treatment or prevention of irritable bowel syndrome
WO2015003816A3 (en) Cystobactamides
MX2017001971A (es) Composiciones antimetanogenicas y sus usos.
MX2020001632A (es) Composiciones que comprenden cepas bacterianas.
PH12019502915A1 (en) Immunogenic compositions
EA201991651A1 (ru) Микробный лизоцим для применения в лечении синдрома раздраженного кишечника или воспалительного заболевания кишечника
MA45476B1 (fr) Compositions comprenant des souches bactériennes
MA46980B1 (fr) Compositions comprenant des souches bactériennes